Gabor J Tigyi

Summary

Publications

  1. ncbi Aiming drug discovery at lysophosphatidic acid targets
    Gabor Tigyi
    Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA
    Br J Pharmacol 161:241-70. 2010
  2. ncbi Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions
    Gyongyi N Kiss
    Department of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
    Mol Pharmacol 82:1162-73. 2012
  3. ncbi Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis
    Mari Gotoh
    Department of Physiology, College of Medicine, University of Tennessee Health Science Center, 894 Union Avenue, Memphis, TN 38163, USA
    Biochem Soc Trans 40:31-6. 2012

Collaborators

  • Junming Yue
  • Gyongyi N Kiss
  • Duane D Miller
  • Renuka Gupte
  • Mari Gotoh
  • Jianxiong Liu
  • Suechin Lee
  • Keng G Lim
  • Yuko Fujiwara
  • Stephen Kennel
  • Kimiko Murakami-Murofushi
  • Balazs Sumegi
  • James I Fells
  • Fang Tsyr Lin
  • Renukadevi Patil
  • Ramesh M Ray
  • Jonathan Wall
  • Louisa Balazs
  • James Fells
  • Abby L Parrill
  • Ayako Uchiyama
  • Sue Chin Lee
  • Nora Nusser

Detail Information

Publications3

  1. ncbi Aiming drug discovery at lysophosphatidic acid targets
    Gabor Tigyi
    Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA
    Br J Pharmacol 161:241-70. 2010
    ..However, successful targeting of the pathways associated with this pleiotropic lipid will depend on the future development of as yet undeveloped pharmacons...
  2. ncbi Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions
    Gyongyi N Kiss
    Department of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
    Mol Pharmacol 82:1162-73. 2012
    ....
  3. ncbi Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis
    Mari Gotoh
    Department of Physiology, College of Medicine, University of Tennessee Health Science Center, 894 Union Avenue, Memphis, TN 38163, USA
    Biochem Soc Trans 40:31-6. 2012
    ..In the present article, we review some of the key findings that make the ATX-LPA signalling axis an emerging target for cancer therapy...

Research Grants27

  1. Analysis of Radiomitigative Cell Signaling
    Gabor Tigyi; Fiscal Year: 2009
    ..The objective of this grant application is to elucidate the an- tiapoptotic mechanism of action unique to the LPA2 receptor subtype ..
  2. Ligand Recognition by Phospholipid Growth Factor Receptors
    Gabor J Tigyi; Fiscal Year: 2010
    ..Mills at MD Anderson Cancer Center, who will coordinate in vivo testing of anti-metastatic drug candidates, and Dr. Baker (junior faculty), who will assist with photoaffinity labels and mass spectrometry. ..
  3. Analysis of Radiomitigative Cell Signaling
    Gabor J Tigyi; Fiscal Year: 2010
    ..The objective of this grant application is to elucidate the an- tiapoptotic mechanism of action unique to the LPA2 receptor subtype ..
  4. Ligand recognition by growth factor receptors
    Gabor Tigyi; Fiscal Year: 2005
    ..2. Identify residues conferring specificity for sphingolipids in the EDG3/5/6/8 receptor subfamily. 3. Identify residues involved in glycerolipid recognition in the EDG2/4/7 receptor subfamily. ..
  5. THERAPEUTICALLY PROMISING PHOSPHOLIPID GROWTH FACTORS
    Gabor Tigyi; Fiscal Year: 2006
    ..These studies will have a twofold impact: first, advance our understanding of the physiological function of PLGF; and, second, provide new information concerning the regulation of apoptosis by G protein-coupled receptors. ..
  6. Analysis of LPA Signaling through the GPCR-PPARgamma Axis
    Gabor Tigyi; Fiscal Year: 2007
    ..abstract_text> ..
  7. THERAPEUTICALLY PROMISING PHOSPHOLIPID GROWTH FACTORS
    Gabor Tigyi; Fiscal Year: 2002
    ..The biotechnology industry has just begun to explore the utilization of LPA to prevent apoptosis associated with myocardial ischemia, chemotherapy, and AIDS. ..
  8. Ligand Recognition by Phospholipid Growth Factor Receptors
    Gabor Tigyi; Fiscal Year: 2007
    ..Mills at MD Anderson Cancer Center, who will coordinate in vivo testing of anti-metastatic drug candidates, and Dr. Baker (junior faculty), who will assist with photoaffinity labels and mass spectrometry. ..